| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Cellular Biology |
From the Montreal Heart Institute and Department of Medicine (X.Y.Q., Y.-H.Y., L.X., B.B., A.M., D.C., L.R.V., S.N.), Université de Montréal, Quebec, Canada; Department of Pharmacology and Therapeutics (L.X., B.J.J.M.B., S.N.), McGill University, Montreal, Quebec, Canada; Chang Gung Memorial Hospital and Chang Gung University (Y.H.Y.) Tao-Yuan, Taiwan; Department of Radiation and Stress Cell Biology, Department of Clinical Pharmacology (B.J.J.M.B.), University Groningen, The Netherlands; and Department of Pharmacology and Toxicology (D.D.), Dresden University of Technology, Germany.
Correspondence to Stanley Nattel, Montreal Heart Institute/University of Montreal, Department of Medicine and Research Center, 5000 Belanger St East, Montreal, Quebec, H1T 1C8, Canada. E-mail stanley.nattel{at}icm-mhi.org
Atrial tachycardia (AT) downregulates L-type Ca2+ current (ICaL) and causes atrial fibrillation–promoting electric remodeling. This study assessed potential underlying signal transduction. Cultured adult canine atrial cardiomyocytes were paced at 0, 1, or 3 Hz (P0, P1, P3) for up to 24 hours. Cellular tachypacing (P3) mimicked effects of in vivo AT: decreased ICaL and transient outward current (Ito), unchanged ICaT, IKr, and IKs, and reduced action potential duration (APD). ICaL was unchanged in P3 at 2 and 8 hours but decreased by 55±6% at 24 hours. Tachypacing caused Ca2+i accumulation in P3 cells at 2 to 8 hours, but, by 24 hours, Ca2+i returned to baseline. Cav1.2 mRNA expression was not altered at 2 hours but decreased significantly at 8 and 24 hours (32±4% and 48±4%, respectively) and protein expression was decreased (47±8%) at 24 hours only. Suppressing Ca2+i increases during tachypacing with the ICaL blocker nimodipine or the Ca2+ chelator BAPTA-AM prevented ICaL downregulation. Calcineurin activity increased in P3 at 2 and 8 hours, respectively, returning to baseline at 24 hours. Nuclear factor of activated T cells (NFAT) nuclear translocation was enhanced in P3 cells. Ca2+-dependent signaling was probed with inhibitors of Ca2+/calmodulin (W-7), calcineurin (FK-506), and NFAT (INCA6): each prevented ICaL downregulation. Significant APD reductions (
30%) at 24 hours in P3 cells were prevented by nimodipine, BAPTA-AM, W-7, or FK-506. Thus, rapid atrial cardiomyocyte activation causes Ca2+ loading, which activates the Ca2+-dependent calmodulin–calcineurin–NFAT system to cause transcriptional downregulation of ICaL, restoring Ca2+i to normal at the cost of APD reduction. These studies elucidate for the first time the molecular feedback mechanisms underlying arrhythmogenic AT remodeling.
Key Words: atrial fibrillation electrophysiological remodeling arrhythmia mechanisms antiarrhythmic therapy
This article has been cited by other articles:
![]() |
K. Nishida, G. Michael, D. Dobrev, and S. Nattel Animal models for atrial fibrillation: clinical insights and scientific opportunities Europace, February 1, 2010; 12(2): 160 - 172. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Michael, L. Xiao, X.-Y. Qi, D. Dobrev, and S. Nattel Remodelling of cardiac repolarization: how homeostatic responses can lead to arrhythmogenesis Cardiovasc Res, February 15, 2009; 81(3): 491 - 499. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2008 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |